Mangoceuticals announced that its subsidiary, MangoRx Mexico has secured and executed a technical agreement with Emifarma for the initial stages of development and testing of the Company’s Mango ED products intended for the Mexican and Latin American markets.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MGRX:
- Mangoceuticals Subsidiary, MangoRx Mexico, Executes Technical Agreement with Mexican Pharmaceutical Manufacturer for Initial Development and Production of its Mango Erectile Dysfunction (ED) Products
- Mangoceuticals Shareholders Back Strategic Moves at Special Meeting
- Mangoceuticals officially launches ‘PRIME’ by MangoRx
- MangoRx Officially Launches ‘PRIME’ by MangoRx, Powered by Kyzatrex®️ FDA Approved Oral Testosterone Replacement Therapy (TRT) Treatment
- Mangoceuticals launches direct-to-clinics sales division